Craft

Eolo Pharma

Total Funding

$2.7 M

Eolo Pharma Summary

Company Summary

Overview
EOLO Pharma is a clinical research company. It focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases (e.g. type II diabetes, autoimmune, metabolic syndrome, hypertension, atherosclerosis, etc.)
Type
Private
Status
Active
Founded
2017
Website
https://eolo-pharma.com/
Cybersecurity rating
Sectors

Table of Contents

Footer menu